首页>
外国专利>
New unsaturated fatty amino acid derivatives useful e.g. to prepare dermocosmetologic antiradical, anti-inflammatory, anti-pruritic or anticollagenase compositions and to treat skin aging, keratinization and pigmentation disorders
New unsaturated fatty amino acid derivatives useful e.g. to prepare dermocosmetologic antiradical, anti-inflammatory, anti-pruritic or anticollagenase compositions and to treat skin aging, keratinization and pigmentation disorders
Unsaturated fatty amino acid derivatives (I) and their acid addition salts, as drugs, are new. Unsaturated fatty amino acid derivatives of formula (R a)(R b)N-CH 2-(CH(R n)) n-CH=C(R 1)-C(O)-OR (I) and their acid addition salts, as drugs, are new. X : O or NH; R nH or 1-6C alkyl (optionally substituted by halo), preferably H; R 1H, F, Cl or Br, CF 3, CHF 2 or 1-6C alkyl, 1-6C alkenyl or 1-6C alkynyl (optionally substituted by halo), preferably H or F; R : H, 1-6C alkyl or 3-6C cycloalkyl (optionally substituted by halo), preferably H; R a, R bH, 1-6C alkyl or 1-6C acyl, preferably H, or 4-6C hydrocarbon ring; and n : 2-14, preferably 3. Provided that as a new compound (I) is excluded from 6-amino-hex-2-enoic acid, its hydrochloride and trifluoroacetate, 8-amino-oct-2-enoic acid trifluoroacetate, 8-(dimethylamino)-oct-2-enoic acid, 12-(dimethylamino)-dodec-2-enoic acid, 6-(isopropylamino)-2-methyl-hex-2-enoate, ethyl-6-(tert-butylamino)-2-methyl-hex-2-enoate, 6-amino-2-methyl-hex-2-enoate, 7-amino-hept-2-enoate, 7-amino-2-methyl-hept-2-enoate and 7-amino-4-methyl-hept-2-enoate. Independent claims are included for: (1) the preparation of (I); and (2) an ester compound of formula PG-N(R d)-CH 2-(CHR 1)-C(O)-OR c (VIII). R cH or 1-6C alkyl; R 1H, F, Cl, Br, -CF 3 or -CHF 2, or 1-6C alkyl, alkenyl or alkynyl (optionally substituted by halo, preferably F); PG : a protecting group forming a carbamate group, preferably tert. butyl carbamate or benzyl carbamate, and R dH or PG, provided that (VIII) is excluded from tert-butyl-(E)-6-(N,N-di-tert-butoxycarbonylamino)-hex-2-tert-enoate, ethyl (E)-6-(N-tert-butoxy-carbonylamino)-hex-2-enoate, methyl-(E)-7-(E-tert-butoxy-carbonylamino)-hept-2-enoate and (E)-7-(E-tert-butoxy-carbonylamino)-hept-2-enoic acid. ACTIVITY : Dermatological; Antiinflammatory; Antipruritic; Vulnerary. MECHANISM OF ACTION : Melanogenesis modulator.
展开▼
机译:作为药物的不饱和脂肪酸氨基酸衍生物(I)及其酸加成盐是新的。式(R a)(R b)N-CH 2-(CH(R n))n-CH = C(R 1)-C(O)-OR(I)的不饱和脂肪酸氨基酸衍生物及其酸加成作为药物的盐是新的。 X:O或NH; R nH或1-6C烷基(任选地被卤素取代),优选为H; R 1H,F,Cl或Br,CF 3,CHF 2或1-6C烷基,1-6C烯基或1-6C炔基(可选被卤素取代),优选H或F; R:H,1-6C烷基或3-6C环烷基(任选被卤素取代),优选为H; R a,R bH,1-6C烷基或1-6C酰基,优选为H或4-6C烃环; n为2-14,优选为3。条件是作为新化合物(I)从6-氨基-己-2-烯酸,其盐酸盐和三氟乙酸盐,8-氨基-辛-2-烯酸三氟乙酸盐中排除, 8-(二甲基氨基)-辛-2-烯酸,12-(二甲基氨基)-十二烷基-烯酸,6-(异丙氨基)-2-甲基-己-2-烯酸酯,乙基-6-(叔丁基氨基) )-2-甲基-己-2-烯酸酯,6-氨基-2-甲基-己-2-烯酸酯,7-氨基庚-2-烯酸酯,7-氨基-2-甲基庚-2-烯酸酯和7-氨基-4-甲基-庚-2-烯酸酯。独立索赔包括:(1)(I)的制备; (2)式PG-N(R d)-CH 2-(CHR 1)-C(O)-OR c(VIII)的酯化合物。 R cH或1-6C烷基; R 1H,F,Cl,Br,-CF 3或-CHF 2或1-6C烷基,烯基或炔基(可选地被卤素取代,优选为F); PG:形成氨基甲酸酯基的保护基,优选叔。氨基甲酸丁酯或氨基甲酸苄酯,以及R dH或PG,前提是(VIII)不包括在叔丁基-(E)-6-(N,N-二叔丁氧羰基氨基)-己-2-叔烯酸酯中(E)-6-(N-叔丁氧基-羰基氨基)-2-烯酸乙酯,(-E)-7-(E-叔丁氧基-羰基氨基)-庚-2-烯酸酯和(E) -7-(E-叔丁氧基-羰基氨基)-庚-2-烯酸。活动:皮肤科;消炎(药;止痒;伤药。作用机理:黑色素生成调节剂。
展开▼